Resumen
Mosquito species, members of the genera Aedes, Anopheles and Culex, are the major vectors of human pathogens including protozoa (Plasmodium sp.), filariae and of a variety of viruses (causing dengue, chikungunya, yellow fever, West Nile). There is lack of efficient methods and tools to treat many of the diseases caused by these major human pathogens, since no efficient vaccines or drugs are available; even in malaria where insecticide use and drug therapies have reduced incidence, 219 million cases still occurred in 2010. Therefore efforts are currently focused on the control of vector populations. Insecticides alone are insufficient to control mosquito populations since reduced susceptibility and even resistance is being observed more and more frequently. There is also increased concern about the toxic effects of insecticides on non-target (even beneficial) insect populations, on humans and the environment. During recent years, the role of symbionts in the biology, ecology and evolution of insect species has been well-documented and has led to suggestions that they could potentially be used as tools to control pests and therefore diseases. Wolbachia is perhaps the most renowned insect symbiont, mainly due to its ability to manipulate insect reproduction and to interfere with major human pathogens thus providing new avenues for pest control. We herein present recent achievements in the field of mosquito Wolbachia symbiosis with an emphasis on Aedes albopictus. We also discuss how Wolbachia symbiosis can be harnessed for vector control as well as the potential to combine the sterile insect technique and Wolbachia-based approaches for the enhancement of population suppression programs.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | S150-S163 |
| Publicación | Acta Tropica |
| Volumen | 132 |
| N.º | 1 |
| DOI | |
| Estado | Published - abr 2014 |
Nota bibliográfica
Funding Information:L.A.M. and L.A.B. were funded by CNPq . Work in Mavingui's group was funded by CNRS and ANR ImmunSymbart .
Financiación
L.A.M. and L.A.B. were funded by CNPq . Work in Mavingui's group was funded by CNRS and ANR ImmunSymbart .
| Financiadores |
|---|
| Agence Nationale de la Recherche |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico |
| CNRS Centre National de la Recherche Scientifique |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Infectious Diseases
- Parasitology
Huella
Profundice en los temas de investigación de 'Harnessing mosquito-Wolbachia symbiosis for vector and disease control'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver